These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 19999130)

  • 1. [Clinical experience with transurethral resection of bladder tumor (TUR-Bt) guided by photodynamic diagnosis (PDD)].
    Inoue K; Kuno T; Fukuhara H; Hamaguchi T; Fukata S; Karashima T; Kamada M; Shuin T; Sakakura N; Kasahara K; Watanabe H; Kozai T; Yasuda M; Kataoka S; Tanimura M; Atsushi K; Furihata M
    Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):661-70. PubMed ID: 19999130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical experience with intravesical instillations of 5-aminolevulinic acid (5-ALA) for the photodynamic diagnosis using fluorescence cystoscopy for bladder cancer].
    Inoue K; Karashima T; Kamada M; Kurabayashi A; Ohtsuki Y; Shuin T
    Nihon Hinyokika Gakkai Zasshi; 2006 Jul; 97(5):719-29. PubMed ID: 16898595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
    Inoue K; Fukuhara H; Shimamoto T; Kamada M; Iiyama T; Miyamura M; Kurabayashi A; Furihata M; Tanimura M; Watanabe H; Shuin T
    Cancer; 2012 Feb; 118(4):1062-74. PubMed ID: 21773973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.
    Ahmad S; Aboumarzouk O; Somani B; Nabi G; Kata SG
    BJU Int; 2012 Dec; 110(11 Pt B):E596-600. PubMed ID: 22758907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy.
    Gakis G; Ngamsri T; Rausch S; Mischinger J; Todenhöfer T; Schwentner C; Schmid MA; Hassan FA; Renninger M; Stenzl A
    World J Urol; 2015 Oct; 33(10):1429-37. PubMed ID: 25595732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced specificity of 5-ALA induced fluorescence in photodynamic diagnosis of transitional cell carcinoma after previous intravesical therapy.
    Grimbergen MC; van Swol CF; Jonges TG; Boon TA; van Moorselaar RJ
    Eur Urol; 2003 Jul; 44(1):51-6. PubMed ID: 12814675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study).
    Kawai T; Matsuyama H; Kobayashi K; Ikeda A; Miyake M; Nishimoto K; Matsushita Y; Nishiyama H; Fujimoto K; Oyama M; Miyake H; Azuma H; Inoue K; Mitsui T; Kawakita M; Oyama C; Mizokami A; Abe T; Kuroiwa H; Kume H
    Int J Urol; 2024 Aug; 31(8):906-912. PubMed ID: 38695571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of photodynamic diagnosis for challenging TUR- Bt cases including muscle invasive bladder cancer, BCG failure or 2nd-TUR.
    Takai T; Inamoto T; Komura K; Yoshikawa Y; Uchimoto T; Saito K; Tanda N; Kouno J; Minami K; Uehara H; Takahara K; Hirano H; Nomi H; Kiyama S; Azuma H
    Asian Pac J Cancer Prev; 2015; 16(6):2297-301. PubMed ID: 25824753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in oncological benefits from second transurethral resection between white-light initial surgery and photodynamic diagnosis-guided initial surgery for primary high-risk non-muscle invasive bladder cancer.
    Miyake M; Nishimura N; Nakahama T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
    Int J Urol; 2024 Aug; 31(8):876-885. PubMed ID: 38687165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of fluorescent control in raising radicality of surgical treatment for superficial bladder cancer].
    Matveev BP; Kudashev BV; Bukharkin BV; Romanov VA; Rubanov IuV
    Urologiia; 2000; (3):22-4. PubMed ID: 11186703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection and single instillation of doxorubicin in patients with non-muscle-invasive bladder cancer.
    Rolevich AI; Zhegalik AG; Mokhort AA; Minich AA; Vasilevich VY; Polyakov SL; Krasny SA; Sukonko OG
    World J Urol; 2017 May; 35(5):745-752. PubMed ID: 27604374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic diagnosis in patients with T1G3 bladder cancer: influence on recurrence rate.
    Stanislaus P; Zaak D; Stadler T; Tritschler S; Knüchel R; Stief CG; Karl A
    World J Urol; 2010 Aug; 28(4):407-11. PubMed ID: 20582546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.
    O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K
    BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Improvement of oncologic results of transurethral resection in the treatment of non-muscle-invasive bladder cancer].
    Zubkov AY; Nuriev IR; Sitdykova ME
    Urologiia; 2021 Jun; (3):110-113. PubMed ID: 34251111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study.
    Denzinger S; Burger M; Walter B; Knuechel R; Roessler W; Wieland WF; Filbeck T
    Urology; 2007 Apr; 69(4):675-9. PubMed ID: 17445650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexaminolevulinate blue light cystoscopy (Hal) assisted transurethral resection of the bladder tumour vs white light transurethral resection of the bladder tumour in non-muscle invasive bladder cancer (NMIBC) : a retrospective analysis.
    Capece M; Spirito L; La Rocca R; Napolitano L; Buonopane R; Di Meo S; Sodo M; Bracale U; Longo N; Palmieri A; Fusco F; Verze P; Califano G; Crocetto F; Imbimbo C; Mirone V; Imperatore V; Creta M
    Arch Ital Urol Androl; 2020 Apr; 92(1):17-20. PubMed ID: 32255316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
    Daniltchenko DI; Riedl CR; Sachs MD; Koenig F; Daha KL; Pflueger H; Loening SA; Schnorr D
    J Urol; 2005 Dec; 174(6):2129-33, discussion 2133. PubMed ID: 16280742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reducing the risk of superficial bladder cancer recurrence with 5-aminolevulinic acid-induced fluorescence diagnosis. Results of a 5-year study].
    Filbeck T; Pichlmeier U; Knuechel R; Wieland WF; Rössler W
    Urologe A; 2003 Oct; 42(10):1366-73. PubMed ID: 14569386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA).
    Inoue K; Matsuyama H; Fujimoto K; Hirao Y; Watanabe H; Ozono S; Oyama M; Ueno M; Sugimura Y; Shiina H; Mimata H; Azuma H; Nagase Y; Matsubara A; Ito YM; Shuin T
    Photodiagnosis Photodyn Ther; 2016 Mar; 13():91-96. PubMed ID: 26751700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexylaminolevulinate photodynamic diagnosis for multifocal recurrent nonmuscle invasive bladder cancer.
    Ray ER; Chatterton K; Thomas K; Khan MS; Chandra A; O'Brien TS
    J Endourol; 2009 Jun; 23(6):983-8. PubMed ID: 19441882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.